1 Zhao JW, Qian F. Analysis on Current Status and Plights of Translational Medicine. J Int Transl Med, 2015, 3(1): 59-66.
2 Geraghty J. Adenomatous polyposis coli and translational medicine. Lancet, 1996, 348(9025): 422.
3 Huang XE. Advances in Translational Medicine of Breast Cancer: From Bench to Bedside. J Int Transl Med, 2015, 3(1): 47-52.
4 Xu GH, Li Y, Zhou LN. Bcl-xl Expression and its Relationships with Clinical Pathological Characteristics, Expression of Estrogen and Progestogen Receptors in Breast Cancer. J Int Transl Med, 2014, 2(4): 434-8.
5 Maurie Buehler, Ellie Guardino, Jung Sik Park, et al. Clinical Application of Fluorescence in Situ Hybridization (FISH) to Detect HER-2 Gene in Breast Cancer. J Int Transl Med, 2014, 2(2): 326-30.
6 Li P, Stratton ZS, Dao M, et al. Probing circulating tumor cells in microfluidics. Lab Chip, 2013, 13(4): 602-9.
7 Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett, 2007, 253(2): 180-204.
8 Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem, 2011, 57(9): 1242-55.
9 Parkinson DR, Dracopoli N, Petty BG, et al. Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med, 2012, 10: 138.
10 Gazzaniga P, Raimondi C, Gradilone A, et al. Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. Ann Oncol, 2011, 22(8): 1929-30.
11 Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer, 2011, 105(6): 847-53.
12 Sieuwerts AM, Kraan J, Bolt J, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst, 2009, 101(1): 61-6.
13 Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends. Theranostics, 2013, 3(6): 377-94.
14 Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer, 2011, 105(6): 847-53.
15 Krebs MG, Hou JM, Sloane R, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol, 2012, 7(2): 306-15.
16 Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med, 2010, 16(9): 398-406.
17 Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods, 2010, 50(4): 289-97.
18 De Giorgi U, Valero V, Rohren E, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol, 2009, 27(20): 3303-11.